Concorde Asset Management, LLC Gsk PLC Transaction History

Concorde Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$42.05 - $47.77 $3.11 Million - $3.53 Million	-73,982 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$40.23 - $47.74 $1.82 Million - $2.16 Million	45,289 Added 157.84%	73,982 $3.22 Million
Q4 2021 Feb 02, 2022	BUY	$38.88 - $45.31 $120,333 - $140,234	3,095 Added 12.09%	28,693 $1.27 Million
Q3 2021 Oct 21, 2021	SELL	$38.79 - $43.16 $2.1 Million - $2.34 Million	-54,167 Reduced 67.91%	25,598 $978,000
Q2 2021 Jul 20, 2021	BUY	$36.52 - $41.46 $1.26 Million - $1.43 Million	34,463 Added 76.07%	79,765 $3.18 Million
Q1 2021 Apr 27, 2021	BUY	$34.27 - $40.01 $1.55 Million - $1.81 Million	45,302 New	45,302 $1.62 Million

177K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $71.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Concorde Asset Management, LLC with notifications on news.